Ward J M, Hagiwara A, Tsuda H, Tatematsu M, Ito N
Tumor Pathology and Pathogenesis Section, National Cancer Institute, Frederick, Maryland 21701-1013.
Jpn J Cancer Res. 1988 Feb;79(2):152-5. doi: 10.1111/j.1349-7006.1988.tb01570.x.
Hyperplastic, preneoplastic and neoplastic urinary bladder lesions induced by bladder carcinogens and toxins in the rat were evaluated for immunoreactivity with polyclonal or monoclonal antibodies to H-ras p21 or binding to peanut lectin with avidin-biotin immunocytochemistry. A low proportion (less than 20%) of hyperplastic and neoplastic bladder lesions induced by N-butyl-N-(4-hydroxybutyl)-nitrosamine and fixed in Bouin's fixative only were immunoreactive on the cell membrane with the antibodies to H-ras p21. Lectin binding was found for these lesions, as well, even in formalin-fixed tissue and for lesions induced by other carcinogens, but not in regenerative bladder hyperplasias after cyclophosphamide exposure or in bladder exposed to bladder tumor promoters. The latter lesions were also not immunoreactive with antibodies to p21. Our results suggest that this relatively simple technique might be used for identification and screening of tumors for involvement of ras oncogenes and carcinogen initiation.
采用抗H-ras p21多克隆或单克隆抗体免疫反应或通过抗生物素蛋白-生物素免疫细胞化学法与花生凝集素结合,对大鼠膀胱致癌物和毒素诱发的增生性、癌前性和肿瘤性膀胱病变进行评估。仅用Bouin固定液固定的、由N-丁基-N-(4-羟丁基)亚硝胺诱发的增生性和肿瘤性膀胱病变中,仅有低比例(不到20%)在细胞膜上对H-ras p21抗体呈免疫反应性。这些病变也发现有凝集素结合,即使在福尔马林固定的组织以及由其他致癌物诱发的病变中也是如此,但在环磷酰胺暴露后的再生性膀胱增生或暴露于膀胱肿瘤促进剂的膀胱中未发现。后一类病变对p21抗体也无免疫反应性。我们的结果表明,这种相对简单的技术可用于鉴定和筛查涉及ras癌基因和致癌物启动的肿瘤。